XML 36 R21.htm IDEA: XBRL DOCUMENT v3.19.2

SEGMENT AND GEOGRAPHIC INFORMATION

6 Months Ended

Jun. 30, 2019

Segment Reporting [Abstract]

SEGMENT AND GEOGRAPHIC INFORMATION

SEGMENT AND GEOGRAPHIC INFORMATION

The Company internally manages two global reportable segments and reports the results of its businesses to its chief operating decision maker. The two reportable segments and their activities are described below.

• The Codman Specialty Surgical segment includes (i) the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment and (ii) the precision tools and instruments business, which sells more than 60,000 instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices.

• The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts and nerve and tendon repair products.

The Corporate and other category includes (i) various executive, finance, human resource, information systems, legal functions, (ii) brand management, and (iii) share-based compensation costs.

The operating results of the various reportable segments as presented are not comparable to one another because (i) certain operating segments are more dependent than others on corporate functions for unallocated general and administrative and/or operational manufacturing functions and (ii) the Company does not allocate certain manufacturing costs and general and administrative costs to the operating segment results. Net sales and profit by each reportable segment for the three and six months ended June 30, 2019 and 2018 are as follows:

	Three Months Ended June 30,								Six Months Ended June 30,
	2019				2018				2019				2018
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	249,258			$	239,504			$	483,826			$	475,619
Orthopedics and Tissue Technologies	134,387				126,686				259,509				247,653
Total revenues	$	383,645			$	366,190			$	743,335			$	723,272
Segment Profit
Codman Specialty Surgical	$	99,241			$	91,118			$	190,622			$	180,609
Orthopedics and Tissue Technologies	41,787				37,141				82,282				69,579
Segment profit	141,028				128,259				272,904				250,188
Amortization	(11,004		)		(5,286)				(16,284		)		(10,676		)
Corporate and other	(84,065		)		(95,339		)		(178,353		)		(186,299		)
Operating income	$	45,959			$	27,634			$	78,267			$	53,213

The Company does not allocate any assets to the reportable segments. No asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenues to geographic areas based on the location of the customer. Total revenue by major geographic area consisted of the following:

	Three Months Ended June 30,								Six Months Ended June 30,
	2019				2018				2019				2018
	(In thousands)
United States	$	273,390			$	259,711			$	530,116			$	508,639
Europe	50,871				51,405				99,511				103,178
Asia Pacific	37,031				35,497				72,731				71,282
Rest of World	22,353				19,577				40,977				40,173
Total Revenues	$	383,645			$	366,190			$	743,335			$	723,272

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510

+ Details

Name:	us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration